MedPath

A clinical study on effect of formulation of Calotropis and turmeric in the management of freckles and melasma i.e darkening of facial skin.

Phase 2
Completed
Conditions
Health Condition 1: null- Mukhakarshnya(hyperpigmentation disorders like freckles, melasma, etc.)
Registration Number
CTRI/2015/02/005504
Lead Sponsor
IPGT and RA GAU Jamnagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patients irrespective of age and sex with clinically significant symptoms of mukha karshnya.

Patients having chronic exposure to sun who have developed freckles.

Exclusion Criteria

Patients with recent history of C.A.

Patients with history of allergic or hypersensitive reaction to any ingredients of the regimen

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary expected outcome will be decrease in number of freckles and size of melasma patches and decrease in darkness of the hyperpigmented skin.Timepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
development of calotropis procera and gigantea formulation in management of hyperpigmentation.Timepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath